Federal Budget Package Increases FDA Funding
The fiscal 2020 federal budget package signed into law on Dec. 20 increased funding for the FDA for the third time in three years.
The budget includes $3.16 billion in appropriations for the agency, an increase of three percent on the fiscal 2019 allocation. Including user fees, the agency’s total budget for fiscal 2020 is $5.8 billion.
Following two previous years of significant increases the agency is no longer “running on fumes” according to the Alliance for a Stronger FDA.
The budget expands funding for human drugs by $20 million to $683 million and for biologics by $12 million to $252 million. It includes additional funding for advanced manufacturing, opioids and rare cancer therapies.
The agency also received additional funding for the 21st Century Cures Act of $5 million for a total of $75 million.
